CYRX vs. ARDX, EVO, ETNB, OCUL, GPCR, IOVA, CALT, AUPH, GYRE, and SNDX
Should you be buying Cryoport stock or one of its competitors? The main competitors of Cryoport include Ardelyx (ARDX), Evotec (EVO), 89bio (ETNB), Ocular Therapeutix (OCUL), Structure Therapeutics (GPCR), Iovance Biotherapeutics (IOVA), Calliditas Therapeutics AB (publ) (CALT), Aurinia Pharmaceuticals (AUPH), Gyre Therapeutics (GYRE), and Syndax Pharmaceuticals (SNDX). These companies are all part of the "pharmaceutical products" industry.
Cryoport vs.
Cryoport (NASDAQ:CYRX) and Ardelyx (NASDAQ:ARDX) are both small-cap transportation companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, community ranking, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.
Ardelyx has higher revenue and earnings than Cryoport. Ardelyx is trading at a lower price-to-earnings ratio than Cryoport, indicating that it is currently the more affordable of the two stocks.
Cryoport presently has a consensus target price of $11.67, indicating a potential upside of 86.97%. Ardelyx has a consensus target price of $10.95, indicating a potential upside of 110.98%. Given Ardelyx's stronger consensus rating and higher probable upside, analysts clearly believe Ardelyx is more favorable than Cryoport.
Ardelyx has a net margin of -11.73% compared to Cryoport's net margin of -70.08%. Cryoport's return on equity of -13.35% beat Ardelyx's return on equity.
92.9% of Cryoport shares are held by institutional investors. Comparatively, 58.9% of Ardelyx shares are held by institutional investors. 10.1% of Cryoport shares are held by company insiders. Comparatively, 5.9% of Ardelyx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Cryoport had 5 more articles in the media than Ardelyx. MarketBeat recorded 10 mentions for Cryoport and 5 mentions for Ardelyx. Ardelyx's average media sentiment score of 0.59 beat Cryoport's score of 0.47 indicating that Ardelyx is being referred to more favorably in the news media.
Ardelyx received 292 more outperform votes than Cryoport when rated by MarketBeat users. Likewise, 67.46% of users gave Ardelyx an outperform vote while only 65.33% of users gave Cryoport an outperform vote.
Cryoport has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Comparatively, Ardelyx has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500.
Summary
Ardelyx beats Cryoport on 12 of the 19 factors compared between the two stocks.
Get Cryoport News Delivered to You Automatically
Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cryoport Competitors List
Related Companies and Tools
This page (NASDAQ:CYRX) was last updated on 3/26/2025 by MarketBeat.com Staff
Buy CYRX Stock Free CYRX Stock Alerts